LSM1P1

Across TCGA pan-cancer cohorts, LSM1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LSM1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LSM1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LSM1P1 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC and BRCA are the cancer types where LSM1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LSM1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.043	.013	6	view →
BRCA	All	III,IV	−0.053	.046	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LSM1P1–KIRC

Open the KIRC breakdown →